Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Coze

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Cancer Treatment Reviews|June 1, 1989
A phase-II study of adoptive immunotherapy with continuous infusion of interleukin-2 in children with advanced neuroblastoma. A report on 11 casesM Favrot, D Floret, J Michon, et al.
Medical and Pediatric Oncology|July 24, 2001
Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie PédiatriqueH Rubie, D Plantaz, C Coze, et al.
Cancer|July 15, 1996
The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A prospective study of 42 patients--results of the NBL 90 Study of the French Society of Pediatric OncologyD Plantaz, H Rubie, J Michon, et al.
International Journal of Cancer|June 19, 1991
Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimensM C Favrot, V Combaret, E Goillot, et al.
Progress in Clinical and Biological Research|January 1, 1994
Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group StudyJ Michon, S Négrier, C Coze, et al.
Bone Marrow Transplantation|January 1, 1991
Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patientsJ M Zucker, T Philip, J L Bernard, et al.
Bone Marrow Transplantation|May 1, 1995
Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour RegistryR Ladenstein, C Lasset, R Pinkerton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow TransplantationR Ladenstein, C Lasset, O Hartmann, et al.
British Journal of Cancer|January 1, 1993
Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 studyT Philip, R Ladenstein, J M Zucker, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
Analysis of parameters for maximal in vitro proliferation and activation of lymphokine-activated killer cells (LAK)C Coze, V Combaret, I Philip, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Cancer Treatment Reviews|June 1, 1989
A phase-II study of adoptive immunotherapy with continuous infusion of interleukin-2 in children with advanced neuroblastoma. A report on 11 casesM Favrot, D Floret, J Michon, et al.
Medical and Pediatric Oncology|July 24, 2001
Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie PédiatriqueH Rubie, D Plantaz, C Coze, et al.
Cancer|July 15, 1996
The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A prospective study of 42 patients--results of the NBL 90 Study of the French Society of Pediatric OncologyD Plantaz, H Rubie, J Michon, et al.
International Journal of Cancer|June 19, 1991
Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimensM C Favrot, V Combaret, E Goillot, et al.
Progress in Clinical and Biological Research|January 1, 1994
Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group StudyJ Michon, S Négrier, C Coze, et al.
Bone Marrow Transplantation|January 1, 1991
Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patientsJ M Zucker, T Philip, J L Bernard, et al.
Bone Marrow Transplantation|May 1, 1995
Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour RegistryR Ladenstein, C Lasset, R Pinkerton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow TransplantationR Ladenstein, C Lasset, O Hartmann, et al.
British Journal of Cancer|January 1, 1993
Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 studyT Philip, R Ladenstein, J M Zucker, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
Analysis of parameters for maximal in vitro proliferation and activation of lymphokine-activated killer cells (LAK)C Coze, V Combaret, I Philip, et al.
Pageof 7